S Nakano1, T Asada, H Matsuda, M Uno, M Takasaki. 1. Department of Geriatric Medicine, National Center Hospital for Mental, Nervous, and Muscular Disorders, 4-1-1, Ogawahigashi, Kodaira, Tokyo 187-8551, Japan.
Abstract
UNLABELLED: The aim of this SPECT study was to investigate the effects of donepezil on regional cerebral blood flow (rCBF) in patients with mild to moderate Alzheimer's disease (AD) using statistical parametric mapping. METHODS:rCBF was noninvasively measured using (99m)Tc-ethyl cysteinate dimer in 35 AD patients with a Mini-Mental State Examination score > 16 on initial evaluation. Baseline and follow-up SPECT studies with a mean interval of 12 mo were performed on these patients. We used the adjusted rCBF images in the relative flow distribution (normalization of global cerebral blood flow for each patient to 50 mL/100 g/min with proportional scaling) to compare these groups through statistical parametric mapping. RESULTS: In the follow-up study, the adjusted rCBF was significantly preserved in the right and left anterior cingulate gyri, right middle temporal gyrus, right inferior parietal lobules, and prefrontal cortex of donepezil-treated AD patients, compared with placebo-treated AD patients. CONCLUSION: Treatment with donepezil for 1 y appears to reduce the decline in rCBF, suggesting preservation of functional brain activity.
RCT Entities:
UNLABELLED: The aim of this SPECT study was to investigate the effects of donepezil on regional cerebral blood flow (rCBF) in patients with mild to moderate Alzheimer's disease (AD) using statistical parametric mapping. METHODS:rCBF was noninvasively measured using (99m)Tc-ethyl cysteinate dimer in 35 ADpatients with a Mini-Mental State Examination score > 16 on initial evaluation. Baseline and follow-up SPECT studies with a mean interval of 12 mo were performed on these patients. We used the adjusted rCBF images in the relative flow distribution (normalization of global cerebral blood flow for each patient to 50 mL/100 g/min with proportional scaling) to compare these groups through statistical parametric mapping. RESULTS: In the follow-up study, the adjusted rCBF was significantly preserved in the right and left anterior cingulate gyri, right middle temporal gyrus, right inferior parietal lobules, and prefrontal cortex of donepezil-treated ADpatients, compared with placebo-treated ADpatients. CONCLUSION: Treatment with donepezil for 1 y appears to reduce the decline in rCBF, suggesting preservation of functional brain activity.
Authors: R Ceravolo; D Volterrani; D Frosini; S Bernardini; C Rossi; C Logi; G Manca; L Kiferle; G Mariani; L Murri; U Bonuccelli Journal: J Neural Transm (Vienna) Date: 2006-06-14 Impact factor: 3.575
Authors: E Stefanova; A Wall; O Almkvist; A Nilsson; A Forsberg; B Långström; A Nordberg Journal: J Neural Transm (Vienna) Date: 2005-07-29 Impact factor: 3.575
Authors: Wenjun Li; Piero G Antuono; Chunming Xie; Gang Chen; Jennifer L Jones; B Douglas Ward; Malgorzata B Franczak; Joseph S Goveas; Shi-Jiang Li Journal: Neuroimage Date: 2012-01-08 Impact factor: 6.556
Authors: Krista L Lanctôt; Nathan Herrmann; Kenneth K Yau; Lyla R Khan; Barbara A Liu; Maysoon M LouLou; Thomas R Einarson Journal: CMAJ Date: 2003-09-16 Impact factor: 8.262
Authors: Cheryl L Grady; Anthony R McIntosh; Sania Beig; Michelle L Keightley; Hana Burian; Sandra E Black Journal: J Neurosci Date: 2003-02-01 Impact factor: 6.167
Authors: María Lacalle-Aurioles; José M Mateos-Pérez; Juan A Guzmán-De-Villoria; Javier Olazarán; Isabel Cruz-Orduña; Yasser Alemán-Gómez; María-Elena Martino; Manuel Desco Journal: J Cereb Blood Flow Metab Date: 2014-01-15 Impact factor: 6.200